Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Targeted Anticancer Therapies Congress 2024

Start date: 26 Feb 2024
End date: 28 Feb 2024
Location: Paris, France

The ESMO Targeted Anticancer Therapies Congress 2024, took place from 26 to 28 February 2024 in Paris, France.

The congress offered participants a glimpse into the future of anticancer therapies, focusing on promising new targets and agents with a particular emphasis on early drug development.

Speakers from both academia and industry participated in an expanded programme, including four new special sessions with industry addressing drug development, methodological, regulatory, strategic financing and investment issues, offering attendees a fresh, wide-ranging perspective on the development of innovative cancer therapeutics and their optimal implementation.